熱門資訊> 正文
Maravai Lifesciences任命Rajesh Asarpota为首席财务官
2025-06-26 04:08
- Maravai LifeSciences (NASDAQ:MRVI) announced that Rajesh Asarpota has been appointed executive vice president and chief financial officer effective June 30, 2025.
- He will succeed Kevin Herde, who is transitioning to an advisory role on the same date to support an effective transition, the company added.
- Source: Press Release
More on Maravai LifeSciences Holdings
- Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive
- Maravai LifeSciences appoints Bernd Brust as CEO
- Maravai LifeSciences Holdings Q1 2025 Earnings Preview
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
